- Home
- EQH vs KTTA Comparison
EQH vs KTTA Comparison
Compare EQH & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQH
- KTTA
- Stock Information
- Founded
- EQH 1859
- KTTA 2020
- Country
- EQH United States
- KTTA United States
- Employees
- EQH N/A
- KTTA 4
- Industry
- EQH Specialty Insurers
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- EQH Finance
- KTTA Health Care
- Exchange
- EQH Nasdaq
- KTTA Nasdaq
- Market Cap
- EQH 16.2B
- KTTA 5.5M
- IPO Year
- EQH N/A
- KTTA 2021
- Fundamental
- Price
- EQH $53.54
- KTTA $0.72
- Analyst Decision
- EQH Buy
- KTTA
- Analyst Count
- EQH 11
- KTTA 0
- Target Price
- EQH $64.55
- KTTA N/A
- AVG Volume (30 Days)
- EQH 2.6M
- KTTA 201.4K
- Earning Date
- EQH 11-03-2025
- KTTA 11-12-2025
- Dividend Yield
- EQH 2.05%
- KTTA N/A
- EPS Growth
- EQH N/A
- KTTA N/A
- EPS
- EQH 1.38
- KTTA N/A
- Revenue
- EQH $13,960,000,000.00
- KTTA N/A
- Revenue This Year
- EQH $17.36
- KTTA N/A
- Revenue Next Year
- EQH $1.25
- KTTA N/A
- P/E Ratio
- EQH $38.27
- KTTA N/A
- Revenue Growth
- EQH 21.29
- KTTA N/A
- 52 Week Low
- EQH $40.81
- KTTA $0.65
- 52 Week High
- EQH $56.61
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- EQH 52.46
- KTTA 43.23
- Support Level
- EQH $52.52
- KTTA $0.74
- Resistance Level
- EQH $54.43
- KTTA $0.81
- Average True Range (ATR)
- EQH 1.17
- KTTA 0.06
- MACD
- EQH -0.01
- KTTA -0.01
- Stochastic Oscillator
- EQH 64.98
- KTTA 9.32
About EQH Equitable Holdings Inc.
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).